2026-01-10 - Analysis Report
Here's a comprehensive analysis of Sempra (SRE) based on the data provided, broken down into sections for clarity:

**1. Return Rate Comparison:**

*   **Company Overview:** Sempra is an energy infrastructure company focused on electricity and natural gas.
*   **SRE Cumulative Return:** 11.97%
*   **VOO (S&P 500) Cumulative Return:** 92.74%
*   **Divergence:** -76.9 (Current divergence is -76.9 compared to the S&P 500's cumulative return.)
*   **Relative Divergence:** 8.3 (The current divergence sits at the 8.3rd percentile of its historical range, suggesting it's closer to its minimum divergence than its maximum).
*   **Analysis:** Sempra has significantly underperformed the S&P 500 over the tracked period. The relative divergence suggests this underperformance is closer to its historical worst than its best.

**Alpha, Beta Analysis**

| Year      | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| --------- | ------- | ------- | ------- | ----- | ------ |
| 2016-2018 | 1.0%    | 10.9%   | -3.0%   | 0.4   | 35.6   |
| 2017-2019 | 32.0%   | 10.9%   | 14.0%   | 0.3   | 49.9   |
| 2018-2020 | -4.0%   | 43.5%   | -25.0%  | 0.8   | 42.0   |
| 2019-2021 | -2.0%   | 43.5%   | -46.0%  | 0.9   | 43.6   |
| 2020-2022 | -14.0%  | 43.5%   | -12.0%  | 0.8   | 50.9   |
| 2021-2023 | 22.0%   | 12.9%   | 21.0%   | 0.6   | 49.2   |
| 2022-2024 | 11.0%   | 12.9%   | -9.0%   | 0.5   | 57.8   |
| 2023-2025 | -14.0%  | 28.7%   | -76.0%  | 0.6   | 58.1   |

*   **CAGR:** Fluctuates significantly, showing periods of both strong growth and decline.
*   **MDD (Maximum Drawdown):**  High MDD in some periods (e.g., 43.5% in 2018-2020, 2019-2021, 2020-2022) indicates substantial risk and potential for significant losses.
*   **Alpha:**  Frequently negative, suggesting SRE has underperformed its benchmark on a risk-adjusted basis. The -76% alpha for 2023-2025 is particularly concerning. Periods with positive Alpha appear, showing that sometimes it outperform the risk-adjusted benchmark.
*   **Beta:**  Ranges from 0.3 to 0.9. A beta less than 1 suggests that the stock is less volatile than the overall market.
*   **Cap(B) (Market Cap in Billions):** Generally increasing trend over time, indicating company growth.

**2. Recent Stock Price Fluctuations:**

*   **Close:** 88.03
*   **Last Market Data:** Price: 88.82, Previous Close: 88.03, Change: 0.9
*   **5-day SMA:** 87.868
*   **20-day SMA:** 88.1925
*   **60-day SMA:** 90.738
*   **Analysis:** The stock price is currently below both its 20-day and 60-day simple moving averages, which *could* indicate a short-term downtrend. The 5-day SMA is slightly below the 20-day SMA, suggesting a potential recent downward pressure.

**3. RSI, PPO, and Expected Return:**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI:** 55.71 (Neutral, not overbought or oversold)
*   **PPO:** 0.0156 (Very close to zero, indicating minimal momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 3.8 (+): 단기상승 (Short-term increase)
*   **Expected Return:** -354.2% (Very negative, suggesting significant expected underperformance compared to S&P 500 in the long term)
*   **Analysis:** The MRI suggests a medium investment risk.  The RSI is neutral. The PPO indicates a lack of strong momentum. The expected return is alarmingly negative, indicating significant long-term risk based on the model used to calculate it.

**4. Recent News & Significant Events:**

*   **Insider Selling:**  Multiple reports of Chairman Jeffrey Martin selling shares. This can sometimes be interpreted negatively by the market, as it *could* signal a lack of confidence in the company's future prospects (though there could be other explanations for insider selling).
*   **Analyst/Trading Commentary:** "Trading the Move, Not the Narrative" suggests focusing on short-term price action.
*   **Financial Impact:** Sempra estimates a $471 million after-tax impact to earnings from a proposed decision.
*   **Technical Analysis:** Stock crossed below its 50-day moving average.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.82)
*   **Opinions:** 15 analysts
*   **Target Price:** Average: $100.07, High: $115.00, Low: $87.00
*   **Analysis:** Analyst consensus is generally positive, with a "Buy" rating and a target price above the current price, this suggests potential for future appreciation. However, the recent insider selling should be considered in conjunction with these ratings.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue    |
| ---------- | ---- | ---------- |
| 2025-11-05 | 0.12 | 2.76 B$    |
| 2025-08-07 | 0.71 | 2.70 B$    |
| 2025-05-08 | 1.39 | 3.68 B$    |
| 2024-11-06 | 1.01 | 2.57 B$    |
| 2025-11-05 | 1.01 | 2.57 B$    |

*   **EPS:** Fluctuates significantly, with some quarters showing much lower earnings than others.
*   **Revenue:** Also shows variability.
*   **Analysis:** The inconsistent earnings performance is something to investigate further.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| ------------ | ------- | ------------- |
| 2025-09-30   | $3.15B  | 42.94%        |
| 2025-06-30   | $3.00B  | 46.73%        |
| 2025-03-31   | $3.80B  | 47.21%        |
| 2024-12-31   | $3.76B  | 49.23%        |
| 2024-09-30   | $2.78B  | 44.49%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE     |
| ------------ | -------- | ------- |
| 2025-09-30   | $31.17B | 0.30%   |
| 2025-06-30   | $31.72B | 1.49%   |
| 2025-03-31   | $31.66B | 2.90%   |
| 2024-12-31   | $31.24B | 2.16%   |
| 2024-09-30   | $29.72B | 2.18%   |

*   **Revenue:** Generally shows growth, but with some quarter-to-quarter variation.
*   **Profit Margin:** Relatively high and stable.
*   **Equity:** Increasing over time.
*   **ROE (Return on Equity):**  Fluctuates, with a significant drop in the most recent quarter.
*   **Analysis:** High profit margins are positive, but the recent drop in ROE and inconsistent revenue growth are potential concerns.

**7. Comprehensive Analysis (Summary):**

Sempra (SRE) presents a mixed picture.

*   **Negatives:**
    *   Significant underperformance compared to the S&P 500.
    *   High MDD in some periods, indicating substantial risk and potential for significant losses.
    *   Frequent negative Alpha, suggesting SRE has underperformed its benchmark on a risk-adjusted basis.
    *   Very negative expected return.
    *   Insider selling by the Chairman.
    *   Inconsistent earnings and revenue performance.
    *   Recent drop in ROE.
    *   Stock Price currently below 20 and 60 day Simple Moving Averages.
*   **Positives:**
    *   Positive analyst consensus and target price.
    *   Relatively high and stable profit margins.
    *   Increasing equity.
    *   The MRI suggest a medium investment risk.

**Overall Recommendation:**

Based on this analysis, caution is warranted. The negative expected return, insider selling, and underperformance compared to the S&P 500 are significant red flags. The positive analyst ratings should be viewed with skepticism in light of these other factors.

**Further Research:**

*   Investigate the reasons for the insider selling.
*   Understand the reasons for the recent drop in ROE.
*   Analyze Sempra's debt levels and cash flow.
*   Research the specific regulatory environment Sempra operates in and its potential impact.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.